表紙
市場調查報告書

內臟器官功能化驗:醫療設備開發平台評估,2020年

Organ Function Assays - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 955244
出版日期 內容資訊 英文
訂單完成後即時交付
價格
內臟器官功能化驗:醫療設備開發平台評估,2020年 Organ Function Assays - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年08月01日內容資訊: 英文
簡介

內臟器官功能化驗,是反映明確的內臟器官功能障礙和疾病的一連串的檢驗,包含腎臟,肝臟,胰臟,甲狀腺等的檢驗設備。

本報告廣泛網羅現在開發推動的內臟器官功能化驗,提供包含產品、許可證、開發合作等主要開發中產品的評估,以及主要的臨床實驗的資料。

調查範圍

  • 廣泛地網羅開發中的內臟器官功能化驗
  • 產品的說明,許可證,合作詳細內容,其他開發活動等,評估主要的開發中產品
  • 內臟器官功能化驗的開發相關主要的組織和全部的開發平台計劃列表
  • 從早期開發介紹到核准/發行階段的各種開發階段的開發中產品
  • 開發中產品的主要的臨床實驗資料
  • 市場區隔/產業的最新趨勢

目錄

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 各開發階段的開發中產品
  • 各地區的開發中產品
  • 各批審階段的開發中產品
  • 各核准預定日的開發中產品
  • 進行中的臨床試驗

第4章 各公司開發中的開發中產品

  • 各開發階段的開發中產品

第5章 企業與產品概要

  • Boditech Med Inc
  • China Medical Technologies Inc(Inactive)
  • Cornell University
  • Daxor Corp
  • DSX Therapeutics LLC
  • French National Institute of Health and Medical Research
  • HepQuant Llc
  • Merck Millipore Corp
  • Myriad Genetics Inc
  • Proteome Sciences Plc
  • Radboud University Medical Centre
  • Schnellgen, Inc

第6章 最新趨勢

第7章 附錄

目錄

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 內臟器官功能化驗-各開發階段的開發中產品
  • 內臟器官功能化驗-各地區的開發中產品
  • 內臟器官功能化驗-各法規通行證的開發中產品
  • 內臟器官功能化驗-各核准預定日開發中產品
  • 內臟器官功能化驗-進行中的臨床試驗

第4章 內臟器官功能化驗-企業開發中的開發中產品

  • 內臟器官功能化驗企業-各開發階段的開發中產品
  • 內臟器官功能化驗-各開發階段的開發中產品

第5章 內臟器官功能化驗企業與產品概要

  • Boditech Med Inc企業概要
  • China Medical Technologies Inc(Inactive)企業概要
  • 康乃爾大學的企業概要
  • Daxor Corp企業概要
  • DSX Therapeutics LLC企業概要
  • French National Institute of Health and Medical Research企業概要
  • HepQuant Llc企業概要
  • Merck Millipore Corp企業概要
  • Myriad Genetics Inc企業概要
  • Proteome Sciences Plc企業概要
  • Radboud University醫療中心企業概要
  • Schnellgen, Inc企業概要

第6章 內臟器官功能化驗-最近的開發

第7章 附錄

目錄
Product Code: GDME0972EPD

GlobalData's Medical Devices sector report, "Organ Function Assays - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Organ Function Assays pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Organ Function Assays are the group of tests that reflects distinct organ dysfunction/disease. This category includes kidney, liver, pancreatic and thyroid etc.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Organ Function Assays under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Organ Function Assays and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Organ Function Assays under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

2 Introduction

3 Products under Development

  • 3.1 Organ Function Assays - Pipeline Products by Stage of Development
  • 3.2 Organ Function Assays - Pipeline Products by Territory
  • 3.3 Organ Function Assays - Pipeline Products by Regulatory Path
  • 3.4 Organ Function Assays - Pipeline Products by Estimated Approval Date
  • 3.5 Organ Function Assays - Ongoing Clinical Trials

4 Organ Function Assays - Pipeline Products under Development by Companies

  • 4.1 Organ Function Assays Companies - Pipeline Products by Stage of Development
  • 4.2 Organ Function Assays - Pipeline Products by Stage of Development

5 Organ Function Assays Companies and Product Overview

  • 5.1 Boditech Med Inc Company Overview
  • 5.2 China Medical Technologies Inc (Inactive) Company Overview
  • 5.3 Cornell University Company Overview
  • 5.4 Daxor Corp Company Overview
  • 5.5 DSX Therapeutics LLC Company Overview
  • 5.6 French National Institute of Health and Medical Research Company Overview
  • 5.7 HepQuant Llc Company Overview
  • 5.8 Merck Millipore Corp Company Overview
  • 5.9 Myriad Genetics Inc Company Overview
  • 5.10 Proteome Sciences Plc Company Overview
  • 5.11 Radboud University Medical Centre Company Overview
  • 5.12 Schnellgen, Inc Company Overview

6 Organ Function Assays- Recent Developments

7 Appendix

List of Tables

  • Table 1: Organ Function Assays - Pipeline Products by Stage of Development
  • Table 2: Organ Function Assays - Pipeline Products by Territory
  • Table 3: Organ Function Assays - Pipeline Products by Regulatory Path
  • Table 4: Organ Function Assays

List of Figures

  • Figure 1: Organ Function Assays - Pipeline Products by Stage of Development
  • Figure 2: Organ Function Assays - Pipeline Products by Territory
  • Figure 3: Organ Function Assays - Pipeline Products by Regulatory Path
  • Figure 4: Organ Function Assays - Pipeline Products by Estimated Approval Date
  • Figure 5: Organ Function Assays - Ongoing Clinical Trials